George Simeon
CEO at Curevo Vaccine
George Simeon is CEO at Curevo Vaccine. He founded Curevo Vaccine, which was acquired by Eli Lilly. His expertise includes vaccines, biotech, and corporate strategy.
-
Curevo Vaccine CEO · current
-
Curevo Executive Officer, Director 2022–2019, Former Chairman & Chief Executive Officer 2019 · past
-
Black Kactus LLC CEO 2018–2020 · past
-
SK Telecom Healthcare Strategy Team 2014–2018 · past
-
HealthLink Global Founder 2012–2018 · past
-
GHX Europe Vice-President - Multinational Supplier Business Unit 2011–2012 · past
-
GS1 Senior Advisor 2006–2010 · past
-
Forth Photonics Ltd CEO 2003 · past
-
Johnson & Johnson European Vice-President Cordis Neurovascular 2000–2002, Director Cordis Endovascular Division (France) 1999–2000, Director Reimbursement and Government Relations (Cordis) 1997–1999 · past
-
Novartis Manager Economic Evaluation 1994–1997 · past
Education
-
Università Bocconi Master of Philosophy - MPhil, Strategy & Technology Management · 2004–2007
-
INSEAD MBA · 1998–1999
-
Yale School of Public Health Master of Public Health - MPH, Epidemiology, Health Economics · 1992–1994
-
University of Ottawa B.Soc.Sc, Economics · 1988–1992
Organizations
See all 10-
Curevo Vaccine CEO · current
-
Curevo Executive Officer, Director 2022–2019, Former Chairman & Chief Executive Officer 2019 · past
-
Black Kactus LLC CEO 2018–2020 · past
Education
-
Università Bocconi Master of Philosophy - MPhil, Strategy & Technology Management · 2004–2007
-
INSEAD MBA · 1998–1999
-
Yale School of Public Health Master of Public Health - MPH, Epidemiology, Health Economics · 1992–1994
-
University of Ottawa B.Soc.Sc, Economics · 1988–1992
